SCHEMBL8690487

SCHEMBL8690487

O=C1NC(Cc2cn(CC(=O)c3ccccc3)c3ccccc23)C(=O)S1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 1/20 0.50
PLK1 P53350 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MCL1 Q07820 2/20 0.37
TBXAS1 P24557 1/20 0.36
AKR1A1 P14550 1/20 0.36
AKR1B1 P15121 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MGAM O43451 1/20 0.35
AMY1A P0DUB6 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
RAB9A P51151 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8690584 0.88 KMT2A (0.41) KMT2AMEN1PLK1SMN1; SMN2MGAM
SCHEMBL8685510 0.82 HTR6 (0.49) ALDH1A1POLB
SCHEMBL8685513 0.82 CYP19A1 (0.47) KMT2AMEN1NPSR1ALDH1A1POLB
SCHEMBL8690476 0.79 KMT2A (0.51) KMT2AMEN1PLK1NPSR1SMN1; SMN2
SCHEMBL8811671 0.78 CHRNB2 (0.51) NPSR1POLB
SCHEMBL8813439 0.78 HTR6 (0.50) KMT2AMEN1SMN1; SMN2POLB
SCHEMBL8809547 0.77 ICMT (0.41)
SCHEMBL8809916 0.77 HDAC3 (0.35) KMT2AMEN1POLB
SCHEMBL8810496 0.77 HTR6 (0.49) NPSR1ALDH1A1MAPT
SCHEMBL8811311 0.77 NPC1 (0.50) KMT2AMEN1NPSR1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed